We are live on ! Find out more
TAM

TFG Asset Management Portfolio holdings

AUM $635M Turnover 36.96%
1-Year Est. Return 28.07%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+28.07%
3 Year Est. Return
+72.07%
5 Year Est. Return
+87.41%
10 Year Est. Return
+132.97%
AUM
$621M
AUM Growth
+$183M
Cap. Flow
+$15.3M
Cap. Flow %
2.47%
Top 10 Hldgs %
84.3%
Holding
40
New
7
Increased
12
Reduced
5
Closed
3
Avg Time Held Equity + Options
1.3 years
Top 10 Avg Time Held Equity + Options
1.2 years
Top 20 Avg Time Held Equity + Options
1.3 years
Avg Time Held Equity only
1.3 years
Top 10 Avg Time Held Equity only
1.2 years
Top 20 Avg Time Held Equity only
1.3 years

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$57.3M
2
WK icon
Workiva
WK
+$10.3M
3
SRRK icon
Scholar Rock
SRRK
+$3.25M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$3.22M
5
DYN icon
Dyne Therapeutics
DYN
+$1.52M

Top Sells

Rank Stock Value
1
INFA icon
Informatica
INFA
+$14M
2
BVN icon
Compañía de Minas Buenaventura
BVN
+$867K
3
OTLY icon
Oatly Group
OTLY
+$798K
4
KROS icon
Keros Therapeutics
KROS
+$743K
5
CCJ icon
Cameco
CCJ
+$108K

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.87%
2 Technology 35.85%
3 Healthcare 11.95%
4 Energy 8.07%
5 Materials 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PATH icon
1
UiPath
PATH
$6.97B
$176M 28.3%
13,722,244
+4,772,244
+53% +$57.3M
2022 Q1
13 quarters
HYG icon
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$66.3M 10.68%
822,000
-779,900
-49% -$61.4M
2024 Q1
5 quarters
KGEI icon
3
Kolibri Global Energy
KGEI
$239M
$48.7M 7.84%
7,068,857
-1,711
-0% -$11.8K
2023 Q4
6 quarters
AUTL icon
4
Autolus Therapeutics
AUTL
$455M
$21.7M 3.49%
9,500,000
+900,000
+10% +$1.49M
2018 Q2
28 quarters
CXM icon
5
Sprinklr
CXM
$1.36B
$18.6M 3%
2,200,000
– –
2022 Q1
13 quarters
LYFT icon
6
Lyft
LYFT
$6.37B
$15.8M 2.54%
1,000,000
– –
2021 Q4
14 quarters
WK icon
7
Workiva
WK
$4.21B
$10.3M 1.65%
+150,000
New +$10.3M
2025 Q2
0 quarters
TARS icon
8
Tarsus Pharmaceuticals
TARS
$3.44B
$10.1M 1.63%
250,000
+71,530
+40% +$3.22M
2023 Q2
8 quarters
ANNX icon
9
Annexon
ANNX
$675M
$6.74M 1.09%
2,810,000
+160,000
+6% +$321K
2024 Q2
4 quarters
CLDX icon
10
Celldex Therapeutics
CLDX
$2.22B
$6.43M 1.04%
316,150
+55,150
+21% +$1.07M
2024 Q4
2 quarters
HYG icon
11
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$5.54M 0.89%
68,660
+5,518
+9% +$435K
2022 Q4
10 quarters
TECX icon
12
Tectonic Therapeutic
TECX
$416M
$4.55M 0.73%
228,832
+41,332
+22% +$838K
2025 Q1
1 quarter
AXSM icon
13
Axsome Therapeutics
AXSM
$8.62B
$4.34M 0.7%
41,531
+7,725
+23% +$818K
2024 Q4
2 quarters
SRRK icon
14
Scholar Rock
SRRK
$4.97B
$3.67M 0.59%
+103,482
New +$3.25M
2025 Q2
0 quarters
ACAD icon
15
Acadia Pharmaceuticals
ACAD
$3.39B
$3.48M 0.56%
161,396
+54,396
+51% +$1.01M
2025 Q1
1 quarter
PHVS icon
16
Pharvaris
PHVS
$2.08B
$3.31M 0.53%
188,100
+61,105
+48% +$984K
2025 Q1
1 quarter
RLAY icon
17
Relay Therapeutics
RLAY
$3.81B
$2.42M 0.39%
699,000
+80,000
+13% +$238K
2025 Q1
1 quarter
IMVT icon
18
Immunovant
IMVT
$5.73B
$2.37M 0.38%
147,817
+16,650
+13% +$252K
2025 Q1
1 quarter
SNOW icon
19
Snowflake
SNOW
$116B
$2.24M 0.36%
10,000
– –
2021 Q4
14 quarters
KROS icon
20
Keros Therapeutics
KROS
$220M
$1.71M 0.28%
128,000
-55,000
-30% -$743K
2024 Q4
2 quarters
CCJ icon
21
Cameco
CCJ
$36B
$1.43M 0.23%
19,280
-2,020
-9% -$108K
2025 Q1
1 quarter
AMLX icon
22
Amylyx Pharmaceuticals
AMLX
$3.51B
$1.4M 0.23%
+218,750
New +$1.06M
2025 Q2
0 quarters
DYN icon
23
Dyne Therapeutics
DYN
$2.83B
$1.32M 0.21%
+138,375
New +$1.52M
2025 Q2
0 quarters
HBM icon
24
Hudbay
HBM
$10.6B
$1.14M 0.18%
107,000
– –
2024 Q3
3 quarters
ALKS icon
25
Alkermes
ALKS
$6.71B
$447K 0.07%
+15,632
New +$465K
2025 Q2
0 quarters
1
2

Similar funds

GRR
Golden Reserve Retirement Dublin, Ohio $635M AUM 25.04% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $635M AUM 14.36% 1-Year Est. Return
MPIA
Mountain Pacific Investment Advisers Boise, Idaho $635M AUM 26.7% 1-Year Est. Return
AFG
Altiora Financial Group Lebanon, Ohio $634M AUM 13.93% 1-Year Est. Return
MCM
Maytus Capital Management New York $636M AUM 131.32% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return
BAM
BOCHK Asset Management Hong Kong $634M AUM 64.99% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $637M AUM 25.11% 1-Year Est. Return

TFG Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, TFG Asset Management held 40 positions worth $621M, up 42% from $438M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

TFG Asset Management's Q2 2025 filing shows 7 new, 12 increased, 5 reduced and 3 closed positions. Its largest new stake was Workiva: 150,000 shares worth $10.3M. The largest sale was Informatica, an estimated $14M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

  • TFG Asset Management's largest Q2 2025 buy was Workiva: 150,000 shares worth $10.3M.
  • TFG Asset Management added most to UiPath in Q2 2025, an estimated $57.3M increase.
  • TFG Asset Management's biggest Q2 2025 reduction was Keros Therapeutics, cutting an estimated $743K.
  • TFG Asset Management fully exited Informatica in Q2 2025, selling an estimated $14M.
  • TFG Asset Management's ten largest holdings make up 84% of its $621M portfolio in Q2 2025.
  • TFG Asset Management opened 7 new positions and closed 3 in Q2 2025.
  • TFG Asset Management's portfolio value rose 42% quarter-over-quarter to $621M.

Based on TFG Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.